Axogen, Inc. financial data

Symbol
AXGN on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
13631 Progress Blvd., Suite 400, Alachua, FL
State of incorporation
MN
Fiscal year end
December 31
Former names
LECTEC CORP /MN/ (to 9/29/2011)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 336 % -10.9%
Quick Ratio 108 % +24.6%
Debt-to-equity 99.1 % +3.22%
Return On Equity -14.9 % +36.9%
Return On Assets -7.49 % +37.9%
Operating Margin -4.7 % +70%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44M shares +2.24%
Common Stock, Shares, Outstanding 44M shares +2.24%
Entity Public Float 314M USD +41.9%
Common Stock, Value, Issued 440K USD +2.33%
Weighted Average Number of Shares Outstanding, Basic 43.9M shares +2%
Weighted Average Number of Shares Outstanding, Diluted 43.9M shares +2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 181M USD +18.8%
Research and Development Expense 29.2M USD +8.37%
Selling and Marketing Expense 87M USD +12.5%
General and Administrative Expense 34.7M USD -12.1%
Costs and Expenses 151M USD +5%
Operating Income (Loss) -8.5M USD +64.4%
Nonoperating Income (Expense) -5.81M USD -1011%
Net Income (Loss) Attributable to Parent -14.3M USD +38.4%
Earnings Per Share, Basic -0.31 USD/shares +45.6%
Earnings Per Share, Diluted -0.31 USD/shares +45.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.7M USD -40%
Accounts Receivable, after Allowance for Credit Loss, Current 24.6M USD +5.87%
Inventory, Net 29.4M USD +27.6%
Assets, Current 86.3M USD -1.36%
Operating Lease, Right-of-Use Asset 14.9M USD +7.3%
Intangible Assets, Net (Excluding Goodwill) 5.22M USD +21.6%
Assets 192M USD -1.36%
Accounts Payable, Current 11.8M USD +31.3%
Liabilities, Current 23M USD -13.6%
Operating Lease, Liability, Noncurrent 19.7M USD -0.97%
Other Liabilities, Noncurrent 94K USD
Liabilities 92.6M USD -4.38%
Retained Earnings (Accumulated Deficit) -292M USD -5.16%
Stockholders' Equity Attributable to Parent 99.4M USD +1.63%
Liabilities and Equity 192M USD -1.36%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.3M USD -65.2%
Net Cash Provided by (Used in) Financing Activities 204K USD -67.8%
Net Cash Provided by (Used in) Investing Activities -3.25M USD -314%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 44M shares +2.24%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -15.3M USD -102%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.7M USD -33.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.66M USD
Deferred Tax Assets, Valuation Allowance 61.1M USD +4.86%
Deferred Tax Assets, Gross 66.2M USD +5%
Depreciation 6.39M USD +93.2%
Payments to Acquire Property, Plant, and Equipment 924K USD -78.5%
Operating Lease, Liability, Current 1.85M USD +69.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards 41.5M USD -2.95%
Amortization of Intangible Assets 262K USD -6.76%
Depreciation, Depletion and Amortization 1.52M USD +114%
Share-based Payment Arrangement, Expense 5M USD +5.41%
Interest Expense 5.15M USD +1699%